Innovotech (TSXV:IOT) Total Operating Expense: C$2.36 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Innovotech Total Operating Expense?

Innovotech TSXV:IOT Total Operating Expense is C$2.36 Mil as of Mar. 2026. The stock has 4 warning signs investors should review.

Innovotech's Total Operating Expense for the three months ended in Mar. 2026 was C$0.54 Mil. Innovotech's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 was C$2.36 Mil.

Innovotech Total Operating Expense Related Terms

Innovotech Total Operating Expense Historical Data

* Premium members only.

The historical data trend for Innovotech's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Innovotech Total Operating Expense Chart

Innovotech Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Operating Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.85 0.92 0.86 1.06 2.37

Innovotech Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.55 0.86 0.57 0.40 0.54

Innovotech Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was C$2.36 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Total Operating Expense of C$2.36 Mil mean?
Innovotech (TSXV:IOT) has a Total Operating Expense of C$2.36 Mil as of Mar. 2026. Total operating expense is the primary recurring expense associated with central operations. View historical data on Innovotech and its competitors.
Is Innovotech's Total Operating Expense too high?
Innovotech's current Total Operating Expense is C$2.36 Mil.
How does Innovotech's Total Operating Expense compare to VRTX and REGN?
Innovotech's Total Operating Expense of C$2.36 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Operating Expense for a Biotechnology company?
A good Total Operating Expense depends on the Biotechnology industry context. However, Total Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Operating Expense mean?
A high Total Operating Expense can signal that a stock is expensive relative to its fundamentals. Total operating expense is the primary recurring expense associated with central operations. View historical data on Innovotech and its competitors. Innovotech's current Total Operating Expense is C$2.36 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Innovotech stock overvalued right now?
Based on GuruFocus' analysis, Innovotech (TSXV:IOT) is currently considered Possible Value Trap. The stock's GF Value™ is C$0.27, compared to a current price of C$0.09 — trading 66.7% below its estimated fair value. The current Total Operating Expense is C$2.36 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Operating Expense calculated?
Total Operating Expense is calculated from a company's financial statements. For Innovotech (TSXV:IOT), the current Total Operating Expense is C$2.36 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Innovotech Business Description

Address 2011 - 94 Street, Suite C203, Edmonton, AB, CAN, T6N 1H1
Innovotech Inc is a Canada-based company that provides solutions to clients' biofilm problems through its biofilm contract research department. The core activities of the company are sales of its products, conducting contract research for outside customers, and research and development to identify products for future commercialization. The operating segments of the company include Innovotech and Keystone. Geographically, the firm has a business presence in the United States, Canada, and International, with the majority of the revenue derived from the United States.